53580-21-5 Usage
General Description
4,4,5,5,6,6,6-HEPTAFLUORO-1-PHENYL-1,3-HEXANEDIONE is a chemical compound with the molecular formula C13H4F7O2. It is a fluorinated aromatic ketone that is used primarily in the production of perfluorinated compounds, which have applications as surface coatings, refrigerants, and fire extinguishing agents. 4,4,5,5,6,6,6-HEPTAFLUORO-1-PHENYL-1,3-HEXANEDIONE is a highly reactive and versatile building block for the synthesis of complex molecules with potential applications in pharmaceuticals, agrochemicals, and materials science. 4,4,5,5,6,6,6-HEPTAFLUORO-1-PHENYL-1,3-HEXANEDIONE is considered to be of low environmental concern due to its high volatility and low bioaccumulation potential. However, it is important to handle and use this compound with caution due to its potential health hazards, including respiratory and skin irritation, if not handled properly.
Check Digit Verification of cas no
The CAS Registry Mumber 53580-21-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,5,8 and 0 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 53580-21:
(7*5)+(6*3)+(5*5)+(4*8)+(3*0)+(2*2)+(1*1)=115
115 % 10 = 5
So 53580-21-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H7F7O2/c13-10(14,11(15,16)12(17,18)19)9(21)6-8(20)7-4-2-1-3-5-7/h1-5H,6H2
53580-21-5Relevant articles and documents
Regioselective synthesis of 4-alkyl- and 4-aryl-6-(perfluoroalkyl)salicylic acid derivatives by formal [3+3] cyclocondensation of 1,3-bis(silyloxy)-1,3-butadienes with 3-silyloxy-1-(perfluoroalkyl)prop-2-en-1-ones
Büttner, Stefan,Lubbe, Mathias,Reinke, Helmut,Fischer, Christine,Langer, Peter
, p. 7968 - 7976 (2008/12/20)
4-Alkyl- and 4-aryl-6-(perfluoroalkyl)salicylic acid derivatives were regioselectively prepared by [3+3] cyclization of 1,3-bis(silyl enol ethers) with 3-silyloxy-1-(perfluoroalkyl)prop-2-en-1-ones.
Modulators of LXR
-
, (2008/06/13)
Compounds, compositions and methods for modulating the activity of nuclear receptors are provided. In particular, heterocyclic compounds are provided for modulating the activity of nuclear receptors, including liver X receptor (LXR) and orphan nuclear receptors. In certain embodiments, the compounds are N-substituted pyridones.